Substituted naphthyridine and quinoline compounds as mao inhibitors
The invention provides a chemical entity of Formula (I), wherein R1, R2, R3, Y, and n have any of the values described herein and compositions comprising such chemical entities; methods of making them; and and their use in a wide range of methods, including metabolic and reaction kinetic studies, de...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides a chemical entity of Formula (I), wherein R1, R2, R3, Y, and n have any of the values described herein and compositions comprising such chemical entities; methods of making them; and and their use in a wide range of methods, including metabolic and reaction kinetic studies, detection and imaging techniques, and radioactive treatments; and therapies, including inhibiting MAO and MAO-B selectively, enhancing neuronal plasticity, treating neurological disorders, providing neuroprotection, treating a cognitive or motor impairment associated with a CNS disorder, enhancing the efficiency of cognitive and motor training, providing neurorecovery and neurorehabilitation, enhancing the efficiency of non- human animal training protocols, and treating treating peripheral disorders (including obesity, diabetes, and cardiometabolic disorders) and their associated co-morbidities. |
---|---|
AbstractList | The invention provides a chemical entity of Formula (I), wherein R1, R2, R3, Y, and n have any of the values described herein and compositions comprising such chemical entities; methods of making them; and and their use in a wide range of methods, including metabolic and reaction kinetic studies, detection and imaging techniques, and radioactive treatments; and therapies, including inhibiting MAO and MAO-B selectively, enhancing neuronal plasticity, treating neurological disorders, providing neuroprotection, treating a cognitive or motor impairment associated with a CNS disorder, enhancing the efficiency of cognitive and motor training, providing neurorecovery and neurorehabilitation, enhancing the efficiency of non- human animal training protocols, and treating treating peripheral disorders (including obesity, diabetes, and cardiometabolic disorders) and their associated co-morbidities. |
Author | BASINGER JILLIAN SANTORA VINCENT FREESTONE GRAEME MAK CHIING VALDEZ LINO KAPLAN ALAN PRATT BENJAMIN SENGUPTA DIPANJAN GUPTA VARSHA |
Author_xml | – fullname: PRATT BENJAMIN – fullname: MAK CHIING – fullname: VALDEZ LINO – fullname: SENGUPTA DIPANJAN – fullname: SANTORA VINCENT – fullname: BASINGER JILLIAN – fullname: KAPLAN ALAN – fullname: GUPTA VARSHA – fullname: FREESTONE GRAEME |
BookMark | eNrjYmDJy89L5WRwDi5NKi7JLCktSU1RyEssyCjJqCzKTMnMS1VIzEtRKCzNzMvPAfGS83ML8kvzUooVEosVchPzFTLzMjKTMkvyi4p5GFjTEnOKU3mhNDeDnJtriLOHbmpBfnxqcUFicmpeakm8X5S5oaGppYWjMUEFANmzNBA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | NZ711598A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_NZ711598A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:49:23 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_NZ711598A3 |
Notes | Application Number: NZ20140711598 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160930&DB=EPODOC&CC=NZ&NR=711598A |
ParticipantIDs | epo_espacenet_NZ711598A |
PublicationCentury | 2000 |
PublicationDate | 20160930 |
PublicationDateYYYYMMDD | 2016-09-30 |
PublicationDate_xml | – month: 09 year: 2016 text: 20160930 day: 30 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | DART NEUROSCIENCE (CAYMAN) LTD |
RelatedCompanies_xml | – name: DART NEUROSCIENCE (CAYMAN) LTD |
Score | 3.05981 |
Snippet | The invention provides a chemical entity of Formula (I), wherein R1, R2, R3, Y, and n have any of the values described herein and compositions comprising such... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Substituted naphthyridine and quinoline compounds as mao inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160930&DB=EPODOC&locale=&CC=NZ&NR=711598A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANxvsx5YB6q6DrY-2hQixtNSGtm9BA0y5Tk7ZbD6Rj7cTfx-k64LJblESWY8mxv8TJB_Bg6qbGueGoWqwjQEk1pjLDdCRrKtO7ndSMuTzvGIRW_914nZiTBsy3b2Gqf0K_q88R0aM4-ntZ7dfLv0Msr6qtLB5Zhl35czB2PaVGx5qFAP1J8XquPxp6Q6pQ6oZTJXxzu5j5OPbLHuxjDm3L2j__oyefpCz_x5PgBA5GKEqUp9BIRAuO6JZ2rQWHg_q2G5u14xVnQKWDb271YyKi5QLtu8ow7iQkEjH5WmdCsu8kRJaIS6akgkQF-YxykolFxjLJqXMO7cAf076K2sx-1z0Lp7XW-gU0RS6SKyAGt1KLY1aDKNKIY9NmOENnnHFEcmnHuIbLHUJudo7cwrE03aYK4g6a5Wqd3GOoLVm7MtMP73-FiQ |
link.rule.ids | 230,309,786,891,25585,76894 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUfET-2D2RnTsA_awGNlHUGEQg4bwsqzdJnuwTDbiv-91DPWFt6ZtmvaS692vvbsfwK2maDJjqtGSQwUBSizTFlU1Q7CmUqXTjrWQifeOoaf339TnqTatwMcmF6aoE_pdFEdEjWKo73lxX6d_j1h2EVuZ3dEEuxYP7sS0pRIdyzoC9HvJ7pnOeGSPLMmyTG8mea9mBz0fo_u4A7voXxuiyL7z3hMpKel_e-Iewt4Yl-L5EVQiXoeataFdq8P-sPztxmapeNkxWELB17_6IeFBOkf5LhO0OxEJeEi-VgkX7DsRESHigikpI0FGPoMFSfg8oYng1DmBputMrH4Ld-P_ntv3ZuWulVOo8gWPzoCoTI91hl4Nokg1DLUuxRkKZZQhkovb6jk0tixysXXkBmr9yXDgD568l0s4EGJcR0RcQTVfrqJrNLs5bRYi-wFeBoh8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+naphthyridine+and+quinoline+compounds+as+mao+inhibitors&rft.inventor=PRATT+BENJAMIN&rft.inventor=MAK+CHIING&rft.inventor=VALDEZ+LINO&rft.inventor=SENGUPTA+DIPANJAN&rft.inventor=SANTORA+VINCENT&rft.inventor=BASINGER+JILLIAN&rft.inventor=KAPLAN+ALAN&rft.inventor=GUPTA+VARSHA&rft.inventor=FREESTONE+GRAEME&rft.date=2016-09-30&rft.externalDBID=A&rft.externalDocID=NZ711598A |